palmitoylcarnitine has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askevold, ET; Aukrust, P; Berge, RK; Bjørndal, B; Dahl, CP; Gullestad, L; Nymoen, SH; Svardal, A; Ueland, T; Øie, E | 1 |
| Hassinen, I; Kinnula, VL | 1 |
2 other study(ies) available for palmitoylcarnitine and Chronic Disease
| Article | Year |
|---|---|
Disturbed carnitine regulation in chronic heart failure--increased plasma levels of palmitoyl-carnitine are associated with poor prognosis.
Topics: Adult; Aged; Biomarkers; Carnitine; Chronic Disease; Disease Progression; Female; Heart Failure; Humans; Male; Middle Aged; Palmitoylcarnitine; Prognosis | 2013 |
Effect of chronic hypoxia on hepatic triacylglycerol concentration and mitochondrial fatty acid oxidizing capacity in liver and heart.
Topics: Animals; Caprylates; Chronic Disease; Fatty Acids; Fatty Acids, Nonesterified; Female; Hypoxia; Liver; Male; Mitochondria, Heart; Mitochondria, Liver; Oxidation-Reduction; Oxygen Consumption; Palmitates; Palmitoylcarnitine; Rats; Succinates; Triglycerides | 1978 |